Literature DB >> 8180266

Design and operation of a recombinant mammalian cell manufacturing process for rFVIII.

R Adamson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8180266     DOI: 10.1007/bf01774523

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  4 in total

1.  Large-scale cell culture in biotechnology.

Authors:  W R Arathoon; J R Birch
Journal:  Science       Date:  1986-06-13       Impact factor: 47.728

2.  Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII).

Authors:  D D Pittman; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells.

Authors:  R J Kaufman; L C Wasley; M V Davies; R J Wise; D I Israel; A J Dorner
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

4.  Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.

Authors:  R J Kaufman; L C Wasley; A J Dorner
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

  4 in total
  7 in total

1.  Isolation, characterization and recombinant protein expression in Veggie-CHO: A serum-free CHO host cell line.

Authors:  B Rasmussen; R Davis; J Thomas; P Reddy
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

2.  Hepatitis C and haemophilia.

Authors:  P R Foster; R V McIntosh; A J MacLeod
Journal:  BMJ       Date:  1995-09-16

3.  Evaluation of genetic stability of recombinant human factor VIII by peptide mapping and on-line mass spectrometric analysis.

Authors:  M J Besman; D Shiba
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

4.  High-level expression and purification of a designed angiopoietin-1 chimeric protein, COMP-Ang1, produced in Chinese hamster ovary cells.

Authors:  Su-Jeong Hwang; Sung Hyun Kim; Hak-Zoo Kim; Michel O Steinmetz; Gou Young Koh; Gyun Min Lee
Journal:  Protein J       Date:  2008-08       Impact factor: 2.371

5.  Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII.

Authors:  Kamilla Swiech; Amine Kamen; Sven Ansorge; Yves Durocher; Virgínia Picanço-Castro; Elisa M S Russo-Carbolante; Mário S A Neto; Dimas T Covas
Journal:  BMC Biotechnol       Date:  2011-11-24       Impact factor: 2.563

6.  Stable high-level expression of factor VIII in Chinese hamster ovary cells in improved elongation factor-1 alpha-based system.

Authors:  Nadezhda A Orlova; Sergey V Kovnir; Alexandre G Gabibov; Ivan I Vorobiev
Journal:  BMC Biotechnol       Date:  2017-03-24       Impact factor: 2.563

7.  Blood Clotting Factor VIII: From Evolution to Therapy.

Authors:  N A Orlova; S V Kovnir; I I Vorobiev; A G Gabibov; A I Vorobiev
Journal:  Acta Naturae       Date:  2013-04       Impact factor: 1.845

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.